Drug-Induced Hepatotoxicity
The DOI matches its Crossref record; 182 of the 182 references it cites were found in a registry or an index.
Abstract
Drug-induced hepatic injury accounts for more than 50 percent of cases of acute liver failure in the United States. More than 75 percent of idiosyncratic drug reactions result in liver transplantation or death. This review discusses the pathogenesis of drug-induced liver injury, common adverse drug reactions involving the liver, and the drug-approval process. Monitoring for and recognition of drug-induced hepatotoxicity may prevent some cases of acute hepatic failure.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“It is known that many variables, such as genetic variability, race, sex, age, metabolic capacity, drug-drug interactions, and preexisting diseases, contribute to individual susceptibility and toxicity of idiosyncratic drugs (Lee, 2003).”
From Mitochondrial Dysfunction Induced by Sertraline, an Antidepressant Agent (2012) · cites this paper as Lee, 2003
In the citing paper
“Under these limited conditions, two-dimensional (2D) monolayered cells exhibit altered biological features, including morphology, function, hepatic polarity, and genotype expression (Lasser et al., 2002;Lee, 2003;Ma et al., 2023).”
From Fast formation and maturation enhancement of human liver organoids using a liver-organoid-on-a-chip (2024) · cites this paper as Lee, 2003
Citations
Cites
Incidence of Adverse Drug Reactions in Hospitalized Patients: A Meta-analysis of Prospective Studies
Lazarou, J., Pomeranz, B. H., & Corey, P. N. (1998) · JAMA · doi:10.1001/jama.279.15.1200 · Cited by 4,807
Ostapowicz, G., Fontana, R. J., Schiødt, F. V., Larson, A., Davern, T. J., Han, S. H. B., McCashland, T. M., Shakil, A. O., Hay, J. E., Hynan, L., et al. (2002) · Annals of Internal Medicine · doi:10.7326/0003-4819-137-12-200212170-00007 · Cited by 2,227
Self-citationEarly indicators of prognosis in fulminant hepatic failure
O'Grady, J. G., Alexander, G. J. M., Hayllar, K. M., & Williams, R. (1989) · Gastroenterology · doi:10.1016/0016-5085(89)90081-4 · Cited by 2,085
ACETAMINOPHEN-INDUCED HEPATIC NECROSIS. IV. PROTECTIVE ROLE OF GLUTATHIONE
Mitchell, J. R., Jollow, D. J., Potter, W. Z., Gillette, J. R., & Brodie, B. B. (1973) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)29666-5 · Cited by 1,737
Role of Quinones in Toxicology
Bolton, J. L., Trush, M. A., Penning, T. M., Dryhurst, G., & Monks, T. J. (2000) · Chemical Research in Toxicology · doi:10.1021/tx9902082 · Cited by 1,703
Common and Uncommon Cytochrome P450 Reactions Related to Metabolism and Chemical Toxicity
Guengerich, F. P. (2001) · Chemical Research in Toxicology · doi:10.1021/tx0002583 · Cited by 1,655
Danan, G., & Benichou, C. (1993) · Journal of Clinical Epidemiology · doi:10.1016/0895-4356(93)90101-6 · Cited by 1,481
Jaeschke, H. (2002) · Toxicological Sciences · doi:10.1093/toxsci/65.2.166 · Cited by 1,304
McDonald, G. B., Hinds, M. S., Fisher, L. D., Schoch, H. G., Wolford, J. L., Banaji, M., Hardin, B. J., Shulman, H. M., & Clift, R. A. (1993) · Annals of Internal Medicine · doi:10.7326/0003-4819-118-4-199302150-00003 · Cited by 1,202
Efficacy of Oral N-Acetylcysteine in the Treatment of Acetaminophen Overdose
Smilkstein, M. J., Knapp, G. L., Kulig, K. W., & Rumack, B. H. (1988) · New England Journal of Medicine · doi:10.1056/nejm198812153192401 · Cited by 1,102
Research works printed but not linked: 9
- Yun CH, 1993, Drug Metab Dispos, 21, 403
- Chitturi S, 2001, Semin Gastrointest Dis, 12, 113
- Wang K, 1999, Zhonghua Yi Xue Za Zhi (Taipei), 62, 369
- George J, 1995, Hepatology, 21, 120
- Meadows M, 2001, FDA Consum, 35, 8
- Piliero PJ, 2001, AIDS Read, 11, 379
- 10.1111/j.1572-0241.1999.01091.x · doi:10.1111/j.1572-0241.1999.01091.x · Paper page
- Fernandes NF, 2000, Am J Gastroenterol, 95, 532, 10.1111/j.1572-0241.2000.t01-1-01780.x · doi:10.1111/j.1572-0241.2000.t01-1-01780.x · Paper page
- Graham DJ, 2002, Hepatology, 36, 168A
Cited by
Items 101–200 of 1,000
Goldkind, L., & Laine, L. (2006) · Pharmacoepidemiology and Drug Safety · doi:10.1002/pds.1207 · Cited by 178
New Technologies and Screening Strategies for Hepatotoxicity: Use of In Vitro Models
Dambach, D. M., Andrews, B. A., & Moulin, F. (2005) · Toxicologic Pathology · doi:10.1080/01926230590522284 · Cited by 177
Cho, H.-J., Koh, W.-J., Ryu, Y.-J., Ki, C.-S., Nam, M.-H., Kim, J.-W., & Lee, S.-Y. (2007) · Tuberculosis · doi:10.1016/j.tube.2007.05.012 · Cited by 173
Opportunities for Targeted Therapies in Hepatocellular Carcinoma
Thomas, M. B., & Abbruzzese, J. L. (2005) · Journal of Clinical Oncology · doi:10.1200/jco.2004.00.1537 · Cited by 172
Estes, J. D. (2003) · Archives of Surgery · doi:10.1001/archsurg.138.8.852 · Cited by 177
Developing Structure−Activity Relationships for the Prediction of Hepatotoxicity
Greene, N., Fisk, L., Naven, R. T., Note, R. R., Patel, M. L., & Pelletier, D. J. (2010) · Chemical Research in Toxicology · doi:10.1021/tx1000865 · Cited by 171
Orr, R., & Fiatarone Singh, M. (2004) · Drugs · doi:10.2165/00003495-200464070-00004 · Cited by 167
Watanabe, I., Tomita, A., Shimizu, M., Sugawara, M., Yasumo, H., Koishi, R., Takahashi, T., Miyoshi, K., Nakamura, K., Izumi, T., et al. (2003) · Clinical Pharmacology & Therapeutics · doi:10.1016/s0009-9236(03)00014-6 · Cited by 174
Drug-induced liver injury: present and future
Suk, K. T., & Kim, D. J. (2012) · Clinical and Molecular Hepatology · doi:10.3350/cmh.2012.18.3.249 · Cited by 168
Latchoumycandane, C., Goh, C. W., Ong, M. M. K., & Boelsterli, U. A. (2007) · Hepatology · doi:10.1002/hep.21475 · Cited by 167
Review of the biological properties and toxicity of usnic acid
Araújo, A. A. S., de Melo, M. G. D., Rabelo, T. K., Nunes, P. S., Santos, S. L., Serafini, M. R., Santos, M. R. V., Quintans-Júnior, L. J., & Gelain, D. P. (2015) · Natural Product Research · doi:10.1080/14786419.2015.1007455 · Cited by 160
Assessment of drug-induced hepatotoxicity in clinical practice: A challenge for gastroenterologists
Andrade, R. J. (2007) · World Journal of Gastroenterology · doi:10.3748/wjg.v13.i3.329 · Cited by 157
Drug-Induced Liver Injury in Humans: The Case of Ximelagatran
Keisu, M., & Andersson, T. B. (2009) · Handbook of experimental pharmacology · doi:10.1007/978-3-642-00663-0_13 · Cited by 171
Baillie, T. A., & Rettie, A. E. (2011) · Drug Metabolism and Pharmacokinetics · doi:10.2133/dmpk.dmpk-10-rv-089 · Cited by 160
Gülbay, B. E., Gürkan, Ö. U., Yıldız, Ö. A., Önen, Z. P., Erkekol, F. Ö., Baççıoğlu, A., & Acıcan, T. (2006) · Respiratory Medicine · doi:10.1016/j.rmed.2006.01.014 · Cited by 161
Yang, S., & Kar, S. (2023) · Artificial Intelligence Chemistry · doi:10.1016/j.aichem.2023.100011 · Cited by 193
Evaluation of Drugs With Specific Organ Toxicities in Organ-Specific Cell Lines
Lin, Z., & Will, Y. (2012) · Toxicological Sciences · doi:10.1093/toxsci/kfr339 · Cited by 158
Apoptosis and necrosis in liver disease
Jaeschke, H., Gujral, J. S., & Bajt, M. L. (2004) · Liver International · doi:10.1111/j.1478-3231.2004.0906.x · Cited by 161
Khan, H., Ullah, H., & Nabavi, S. M. (2019) · Food and Chemical Toxicology · doi:10.1016/j.fct.2018.12.002 · Cited by 156
Aspirin and Reye Syndrome: A Review of the Evidence
Schr??r, K. (2007) · Pediatric Drugs · doi:10.2165/00148581-200709030-00008 · Cited by 159
Clay, K. D., Hanson, J. S., Pope, S. D., Rissmiller, R. W., Purdum, P. P., & Banks, P. M. (2006) · Annals of Internal Medicine · doi:10.7326/0003-4819-144-6-200503210-00121 · Cited by 160
Human induced pluripotent stem cells and their use in drug discovery for toxicity testing
Scott, C. W., Peters, M. F., & Dragan, Y. P. (2013) · Toxicology Letters · doi:10.1016/j.toxlet.2013.02.020 · Cited by 171
Liver tissue engineering in the evaluation of drug safety
Dash, A., Inman, W., Hoffmaster, K., Sevidal, S., Kelly, J., Obach, R. S., Griffith, L. G., & Tannenbaum, S. R. (2009) · Expert Opinion on Drug Metabolism & Toxicology · doi:10.1517/17425250903160664 · Cited by 158
He, X., Li, L., Yu, F., Shi, W. S., Li, X., & Ma, H. (2017) · Chemical Science · doi:10.1039/c6sc05712h · Cited by 157
Perinatal Outcomes in Women With Asthma During Pregnancy
Alexander, S., DODDS, L., & ARMSON, B. A. (1998) · Obstetrics and Gynecology · doi:10.1016/s0029-7844(98)00191-4 · Cited by 157
Thiazolidinediones and liver toxicity.
Scheen, A. J. (2001) · PubMed · Cited by 178
Gómez-Lechón, M. J., Castell, J. V., & Donato, M. T. (2006) · Chemico-Biological Interactions · doi:10.1016/j.cbi.2006.10.013 · Cited by 170
Usui, T., Mise, M., Hashizume, T., Yabuki, M., & Komuro, S. (2009) · Drug Metabolism and Disposition · doi:10.1124/dmd.109.028860 · Cited by 153
Assessment of Emerging Biomarkers of Liver Injury in Human Subjects
Schomaker, S., Warner, R., Bock, J., Johnson, K., Potter, D., Van Winkle, J., & Aubrecht, J. (2013) · Toxicological Sciences · doi:10.1093/toxsci/kft009 · Cited by 149
Andrade, R. J., Lucena, I. M., Alonso, A., García-Cort'es, M., García-Ruiz, E., Benitez, R., Fernández, C. M., Pelaez, G., Romero, M., Corpas, R., et al. (2004) · Hepatology · doi:10.1002/hep.20215 · Cited by 153
Pedersen, J. M., Matsson, P., Bergström, C. A. S., Hoogstraate, J., Norén, A., LeCluyse, E. L., & Artursson, P. (2013) · Toxicological Sciences · doi:10.1093/toxsci/kft197 · Cited by 148
Patel, V., & Sanyal, A. J. (2013) · Clinics in Liver Disease · doi:10.1016/j.cld.2013.07.012 · Cited by 149
Evolving concepts in liver tissue modeling and implications for in vitro toxicology
Guillouzo, A., & Guguen-Guillouzo, C. (2008) · Expert Opinion on Drug Metabolism & Toxicology · doi:10.1517/17425255.4.10.1279 · Cited by 145
Teixeira, R. L. D. F., Morato, R. G., Cabello, P. H., Muniz, L. M. K., Moreira, A. D. S. R., Kritski, A. L., Mello, F. C. D. Q., Suffys, P. N., de Miranda, A. B., & Santos, A. R. (2011) · Memórias do Instituto Oswaldo Cruz · doi:10.1590/s0074-02762011000600011 · Cited by 158
Nuclear receptors as therapeutic targets in cholestatic liver diseases
Zollner, G., & Trauner, M. (2009) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2008.00030.x · Cited by 146
Ma, C., Zhao, L., Zhou, E.-M., Xu, J., Shen, S., & Wang, J. (2016) · Analytical Chemistry · doi:10.1021/acs.analchem.5b03869 · Cited by 145
Maternal Toxicity With Continuous Nevirapine in Pregnancy
Hitti, J. E., Frenkel, L. M., Stek, A. M., Nachman, S., Baker, D. A., González-García, A., Provisor, A. J., Thorpe, E. M., Paul, M. E., Foca, M. D., et al. (2004) · JAIDS Journal of Acquired Immune Deficiency Syndromes · doi:10.1097/00126334-200407010-00002 · Cited by 145
Amaral, L., Kristiansen, J. E., Viveiros, M., & Atouguia, J. (2001) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/47.5.505 · Cited by 143
Hepatotoxicity with Thiazolidinediones: Is it a Class Effect?
Scheen, A. J. (2001) · Drug Safety · doi:10.2165/00002018-200124120-00002 · Cited by 151
MRP2 haplotypes confer differential susceptibility to toxic liver injury
Choi, J. H., Ahn, B. M., Yi, J., Lee, J. H., Lee, J. H., Nam, S. W., Chon, C. Y., Han, K.-H., Ahn, S. H., Jang, I.-J., et al. (2007) · Pharmacogenetics and Genomics · doi:10.1097/01.fpc.0000236337.41799.b3 · Cited by 138
Models of Drug Induced Liver Injury (DILI)—Current Issues and Future Perspectives
Kuna, L., Bozic, I., Kizivat, T., Bojanic, K., Mrso, M., Kralj, E., Smolic, R., Wu, G. Y., & Smolic, M. (2018) · Current Drug Metabolism · doi:10.2174/1389200219666180523095355 · Cited by 127
Biochemical mechanisms in drug-induced liver injury: Certainties and doubts
Grattagliano, I., Bonfrate, L., Diogo, C. V., Wang, H. H., Wang, D. Q., & Portincasa, P. (2009) · World Journal of Gastroenterology · doi:10.3748/wjg.15.4865 · Cited by 136
Holt, M., & Ju, C. (2010) · Handbook of Experimental Pharmacology · doi:10.1007/978-3-642-00663-0_1 · Cited by 129
An Update on Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) in Small Animals
Papich, M. G. (2008) · Veterinary Clinics of North America Small Animal Practice · doi:10.1016/j.cvsm.2008.09.002 · Cited by 154
An evaluation of hepatotoxicity in breast cancer patients receiving injection doxorubicin
Damodar, G., Smitha, T., Gopinath, S., Vijayakumar, S., & Rao, Y. (2014) · Annals of Medical and Health Sciences Research · doi:10.4103/2141-9248.126619 · Cited by 134
Cosgrove, B. D., King, B. M., Hasan, M. A., Alexopoulos, L. G., Farazi, P. A., Hendriks, B. S., Griffith, L. G., Sorger, P. K., Tidor, B., Xu, J. J., et al. (2009) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2009.04.002 · Cited by 136
Cholestasis: human disease and experimental animal models
Rodríguez-Garay, E. A. (2003) · Annals of Hepatology · doi:10.1016/s1665-2681(19)32126-x · Cited by 146
Ibáñez, L., Pérez, E., Vidal, X., & Laporte, J. (2002) · Journal of Hepatology · doi:10.1016/s0168-8278(02)00231-3 · Cited by 133
The hepatotoxic metabolite of acetaminophen directly activates the Keap1‐Nrf2 cell defense system†
Copple, I. M., Goldring, C. E., Jenkins, R. E., Chia, A. J. L., Randle, L. E., Hayes, J. D., Kitteringham, N. R., & Park, B. K. (2008) · Hepatology · doi:10.1002/hep.22472 · Cited by 133
Curcumin ameliorates acute thioacetamide‐induced hepatotoxicity
Shapiro, H., Ashkenazi, M., Weizman, N., Shahmurov, M., Aeed, H., & Bruck, R. (2006) · Journal of Gastroenterology and Hepatology · doi:10.1111/j.1440-1746.2005.03984.x · Cited by 142
A randomized controlled trial of acarbose in hepatic encephalopathy
Gentile, S., Guarino, G., Romano, M., Alagia, I., Fierro, M., Annunziata, S., Magliano, P. L., Gravina, A. G., & Torella, R. (2005) · Clinical Gastroenterology and Hepatology · doi:10.1016/s1542-3565(04)00667-6 · Cited by 132
Safety data and withdrawal of hepatotoxic drugs
Babai, S., Auclert, L., & Le-Louët, H. (2018) · Therapies · doi:10.1016/j.therap.2018.02.004 · Cited by 137
Drug Insight: pharmacology and toxicity of thiopurine therapy in patients with IBD
de Boer, N. K. H., Bodegraven, A. A. V., Jharap, B., de Graaf, P., & Mulder, C. J. J. (2007) · Nature Clinical Practice Gastroenterology & Hepatology · doi:10.1038/ncpgasthep1000 · Cited by 128
A Predictive Ligand-Based Bayesian Model for Human Drug-Induced Liver Injury
Ekins, S., Williams, A. J., & Xu, J. J. (2010) · Drug Metabolism and Disposition · doi:10.1124/dmd.110.035113 · Cited by 122
Gap junction inhibition prevents drug-induced liver toxicity and fulminant hepatic failure
Patel, S. J., Milwid, J. M., King, K. R., Bohr, S., Iracheta‐Vellve, A., Li, M., Vitalo, A. G., Parekkadan, B., Jindal, R., & Yarmush, M. L. (2012) · Nature Biotechnology · doi:10.1038/nbt.2089 · Cited by 128
Principles of Conservative Prescribing
Schiff, G. D., Galanter, W. L., Duhig, J., Lodolce, A. E., Koronkowski, M. J., & Lambert, B. L. (2011) · Archives of Internal Medicine · doi:10.1001/archinternmed.2011.256 · Cited by 143
Behr, A.-C., Kwiatkowski, A., Ståhlman, M., Schmidt, F. F., Luckert, C., Braeuning, A., & Buhrke, T. (2020) · Archives of Toxicology · doi:10.1007/s00204-020-02732-3 · Cited by 120
Tolosa, L., Pinto, S., Donato, M. T., Lahoz, A., Castell, J. V., O’Connor, J. E., & Gómez-Lechón, M. J. (2012) · Toxicological Sciences · doi:10.1093/toxsci/kfs083 · Cited by 121
Shaw, P. J., Ganey, P. E., & Roth, R. A. (2010) · Toxicological Sciences · doi:10.1093/toxsci/kfq168 · Cited by 123
High-Content Assays for Hepatotoxicity Using Induced Pluripotent Stem Cell–Derived Cells
Sirenko, O., Hesley, J., Rusyn, I., & Cromwell, E. F. (2014) · ASSAY and Drug Development Technologies · doi:10.1089/adt.2013.520 · Cited by 123
An In Silico Model for Predicting Drug-Induced Hepatotoxicity
He, S., Ye, T., Wang, R., Zhang, C., Zhang, X., Sun, G., & Sun, X. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20081897 · Cited by 127
BASTIDA, G., NOS, P., AGUAS, M., BELTRÁN, B., RUBÍN, Á., DASÍ, F., & PONCE, J. (2005) · Alimentary Pharmacology & Therapeutics · doi:10.1111/j.1365-2036.2005.02636.x · Cited by 121
Ku, N., Michie, S. A., Soetikno, R. M., Resurreccion, E. Z., Broome, R. L., Oshima, R. G., & Omary, M. B. (1996) · Journal of Clinical Investigation · doi:10.1172/jci118864 · Cited by 126
Mitochondrial Dysfunction Induced by Sertraline, an Antidepressant Agent
Li, Y., Couch, L., Higuchi, M., Fang, J.-L., & Guo, L. (2012) · Toxicological Sciences · doi:10.1093/toxsci/kfs100 · Cited by 120
Yang, K., Köck, K., Sedykh, A., Tropsha, A., & Brouwer, K. L. R. (2013) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.23584 · Cited by 114
A Novel Mechanism Underlies the Hepatotoxicity of Pyrazinamide
Shih, T.-Y., Pai, C.-Y., Yang, P., Chang, W.-L., Wang, N.-C., & Hu, O. Y. (2013) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01866-12 · Cited by 119
A high content screening assay to predict human drug-induced liver injury during drug discovery
Persson, M., Løye, A. F., Mow, T. J., & Hornberg, J. J. (2013) · Journal of Pharmacological and Toxicological Methods · doi:10.1016/j.vascn.2013.08.001 · Cited by 120
Acquired Liver Injury in the Intensive Care Unit
Lescot, T., Karvellas, C., Beaussier, M., Magder, S., & Riou, B. (2012) · Anesthesiology · doi:10.1097/aln.0b013e318266c6df · Cited by 117
Kava hepatotoxicity: a clinical survey and critical analysis of 26 suspected cases
Teschke, R., Schwarzenboeck, A., & Hennermann, K.-H. (2008) · European Journal of Gastroenterology & Hepatology · doi:10.1097/meg.0b013e3283036768 · Cited by 119
Goldberg, D. S., Forde, K. A., Carbonari, D. M., Lewis, J. D., Leidl, K. B. F., Reddy, K. R., Haynes, K., Roy, J., Sha, D., Marks, A. R., et al. (2015) · Gastroenterology · doi:10.1053/j.gastro.2015.02.050 · Cited by 113
Acute hepatic failure: A Western perspective
Ostapowicz, G., & Lee, W. M. (2000) · Journal of Gastroenterology and Hepatology · doi:10.1046/j.1440-1746.2000.02074.x · Cited by 118
Self-citationVariant forms of cholestatic diseases involving small bile ducts in adults
Kim, W. (2000) · The American Journal of Gastroenterology · doi:10.1016/s0002-9270(00)00791-7 · Cited by 119
Cai, Y., Yi, J., Zhou, C., & Shen, X. (2012) · PLoS ONE · doi:10.1371/journal.pone.0047769 · Cited by 114
Using controlled clinical trials to learn more about acute drug-induced liver injury
Watkins, P. B., Seligman, P. J., Pears, J. S., Avigan, M. I., & Senior, J. R. (2008) · Hepatology · doi:10.1002/hep.22633 · Cited by 115
He, K., Talaat, R. E., Pool, W. F., Reily, M. D., Reed, J. E., Bridges, A. J., & Woolf, T. F. (2004) · Drug Metabolism and Disposition · doi:10.1124/dmd.32.6.639 · Cited by 115
Molleston, J. P., Fontana, R. J., Lopez, M. J., Kleiner, D. E., Gu, J., Chalasani, N., & Drug‐Induced Liver Injury Network (2011) · Journal of Pediatric Gastroenterology and Nutrition · doi:10.1097/mpg.0b013e31821d6cfd · Cited by 114
Lv, H., Zhu, C., Wei, W., Lv, X., Yu, Q., Deng, X., & Ci, X. (2020) · Phytomedicine · doi:10.1016/j.phymed.2020.153241 · Cited by 117
Zhao, Y., Wang, J., Zhou, G., Shan, L., & Xiao, X. (2009) · Basic & Clinical Pharmacology & Toxicology · doi:10.1111/j.1742-7843.2009.00389.x · Cited by 112
Nanotoxicity Overview: Nano-Threat to Susceptible Populations
Li, Y., Zhang, Y. L., & Yan, B. (2014) · International Journal of Molecular Sciences · doi:10.3390/ijms15033671 · Cited by 119
Recent Progress in Fluorescent Sensors for Drug-Induced Liver Injury Assessment
Chen, J., Huang, D., She, M., Wang, Z., Chen, X., Liu, P., Zhang, S., & Li, J. (2021) · ACS Sensors · doi:10.1021/acssensors.0c02343 · Cited by 113
Human amyloid β‐induced neuroinflammation is an early event in neurodegeneration
Craft, J. M., Watterson, D. M., & Van Eldik, L. J. (2006) · Glia · doi:10.1002/glia.20306 · Cited by 108
Hepatotoxicity of thiazolidinediones
Isley, W. L. (2003) · Expert Opinion on Drug Safety · doi:10.1517/14740338.2.6.581 · Cited by 99
Pharmacogenomics in clinical practice and drug development
Harper, A. R., & Topol, E. J. (2012) · Nature Biotechnology · doi:10.1038/nbt.2424 · Cited by 106
Gulmez, S. E., Larrey, D., Pageaux, G.-P., Lignot, S., Lassalle, R., Jové, J., Gatta, A., McCormick, P. A., Metselaar, H. J., Monteiro, E., et al. (2013) · Drug Safety · doi:10.1007/s40264-012-0013-7 · Cited by 107
Proteomics Investigations of Drug-Induced Hepatotoxicity in HepG2 Cells
Van Summeren, A., Renes, J., Bouwman, F. G., Noben, J.-P., van Delft, J. H. M., Kleinjans, J. C. S., & Mariman, E. C. M. (2011) · Toxicological Sciences · doi:10.1093/toxsci/kfq380 · Cited by 109
Adverse drug reactions and organ damage: The liver
Licata, A. (2016) · European Journal of Internal Medicine · doi:10.1016/j.ejim.2015.12.017 · Cited by 123
Drug-Induced Liver Injury: Review Article
Bleibel, W., Kim, S. H., D'Silva, K. J., & Lemmer, E. R. (2007) · Digestive Diseases and Sciences · doi:10.1007/s10620-006-9472-y · Cited by 124
Elevated Liver Enzymes in Asymptomatic Patients – What Should I Do?
Malakouti, M., Kataria, A., Ali, S., & Schenker, S. (2017) · Journal of Clinical and Translational Hepatology · doi:10.14218/jcth.2017.00027 · Cited by 130
Hegde, M., Jindal, R., Bhushan, A., Bale, S. S., McCarty, W. J., Golberg, I., Usta, O. B., & Yarmush, M. L. (2014) · Lab Chip · doi:10.1039/c4lc00071d · Cited by 104
Nguyen, G. C., Sam, J., & Thuluvath, P. J. (2008) · Hepatology · doi:10.1002/hep.22536 · Cited by 107
Incidence of Statin Hepatotoxicity in Patients With Hepatitis C
Khorashadi, S., Hasson, N. K., & Cheung, R. C. (2006) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2006.03.014 · Cited by 108
Pharmacogenetics and human genetic polymorphisms
Daly, A. K. (2010) · Biochemical Journal · doi:10.1042/bj20100522 · Cited by 103
Using Genome-Wide Association Studies to Identify Genes Important in Serious Adverse Drug Reactions
Daly, A. K. (2011) · The Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev-pharmtox-010611-134743 · Cited by 115
Chemotherapy induced liver abnormalities: an imaging perspective
Sharma, A., Houshyar, R., Bhosale, P., Choi, J., Gulati, R., & Lall, C. G. (2014) · Clinical and Molecular Hepatology · doi:10.3350/cmh.2014.20.3.317 · Cited by 105
Risk assessment and mitigation strategies for reactive metabolites in drug discovery and development
Thompson, R. A., Isin, E. M., Li, Y., Weaver, R. J., Weidolf, L. O. G., Wilson, I. D., Claesson, A., Page, K., Dolgos, H., & Kenna, J. G. (2010) · Chemico-Biological Interactions · doi:10.1016/j.cbi.2010.11.002 · Cited by 109
Hill, A., Mesens, N., Steemans, M., Xu, J. J., & Aleo, M. D. (2012) · Drug Metabolism Reviews · doi:10.3109/03602532.2011.645578 · Cited by 111
In silico Prediction of Drug Induced Liver Toxicity Using Substructure Pattern Recognition Method
Zhang, C., Cheng, F., Li, W., Liu, G., Lee, P. W., & Tang, Y. (2016) · Molecular Informatics · doi:10.1002/minf.201500055 · Cited by 111
Xuan, J., Chen, S., Ning, B., Tolleson, W. H., & Guo, L. (2016) · Chemico-Biological Interactions · doi:10.1016/j.cbi.2015.10.009 · Cited by 103
Sodium valproate induces mitochondrial respiration dysfunction in HepG2 in vitro cell model
Komulainen, T., Lodge, T., Hinttala, R., Bolszak, M., Pietilä, M., Koivunen, P., Hakkola, J., Poulton, J., Morten, K., & Uusimaa, J. (2015) · Toxicology · doi:10.1016/j.tox.2015.03.001 · Cited by 109
Vendemiale, G., Grattagliano, I., Caruso, M. L., Serviddio, G., Valentini, A. M., Pirrelli, M., & Altomare, E. (2001) · Toxicology and Applied Pharmacology · doi:10.1006/taap.2001.9234 · Cited by 109
Metadata
- Authors
- Lee, W. M.
- Affiliations
- The University of Texas Southwestern Medical Center (US)
- Corresponding author
- Lee, William M.
- ORCID
- Lee, William M.
- Venue
- New England Journal of Medicine
- Publisher
- Massachusetts Medical Society
- Published
- 2003-07-31
- Volume
- 349
- Issue
- 5
- Pages
- 474-485
- ISSN
- 0028-4793 (ISSN-L)
- 1533-4406
- OpenAlex
- W3021092633
- Cited by
- 1,594
- References
- 180
- Citations by year
- 2026: 15 · 2025: 14 · 2024: 33 · 2023: 41 · 2022: 44 · 2021: 44 · 2020: 53 · 2019: 69 · 2018: 69 · 2017: 75 · 2016: 84 · 2015: 74 · 2014: 95 · 2013: 88 · 2012: 88
- FWCI
- 5.48
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- New England Journal of Medicine (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Pharmacology › Drug-Induced Hepatotoxicity and Protection
- Health Sciences › Medicine › Hepatology › Liver physiology and pathology
- Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Toxicology › Pharmacovigilance and Adverse Drug Reactions
- Keywords
- drug-induced liver injury, acute liver failure, idiosyncratic drug reactions, adverse drug reactions, drug approval, hepatotoxicity monitoring, liver transplantation
- MeSH terms
- Troglitazone, Anti-Inflammatory Agents, Non-Steroidal, Benzophenones, Bromobenzenes, Chromans, Pharmaceutical Preparations, Humans, Hypoglycemic Agents, Liver, Liver Cirrhosis, Liver Diseases, Liver Function Tests, Pharmacology, Thiazoles, Drug Approval, Thiazolidinediones, Chemical and Drug Induced Liver Injury, Drug-Related Side Effects and Adverse Reactions
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.